Replies to post #213003 on Biotech Values

[DewDiligence]

CEMP PR on reverse merger with Melinta:

https://globenewswire.com/news-release/2017/08/09/1082518/0/en/Cempra-and-Melinta-Announce-Merger-to-Form-Leading-Vertically-Integrated-Commercial-Stage-Anti-Infectives-Company.html

[DewDiligence]

MLNT (Melinta Therapeutics—f/k/a CEMP) implements 1:5 reverse split in conjunction with closing of reverse merger (#msg-133699889):

https://www.sec.gov/Archives/edgar/data/1461993/000119312517333062/d474802d8k.htm